240 related articles for article (PubMed ID: 27605628)
21. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.
Custodio-Patsey L; Donahue RR; Fu W; Lambert J; Smith BN; Taylor BK
Neuropharmacology; 2020 Feb; 163():107726. PubMed ID: 31351975
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats.
Clasen MM; Flax SM; Hempel BJ; Cheng K; Rice KC; Riley AL
Pharmacol Biochem Behav; 2017 Dec; 163():30-35. PubMed ID: 29100992
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.
Cunha TM; Souza GR; Domingues AC; Carreira EU; Lotufo CM; Funez MI; Verri WA; Cunha FQ; Ferreira SH
Mol Pain; 2012 Feb; 8():10. PubMed ID: 22316281
[TBL] [Abstract][Full Text] [Related]
26. Kappa opioid receptors internalization is protective against oxygen-glucose deprivation through β-arrestin activation and Akt-mediated signaling pathway.
Xu J; Chen F; Wang S; Akins NS; Hossain MI; Zhou Y; Huang J; Ji J; Xi J; Lin W; Grothusen J; Le HV; Liu R
Neurochem Int; 2020 Jul; 137():104748. PubMed ID: 32339667
[TBL] [Abstract][Full Text] [Related]
27. Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.
Larson DL; Jones RM; Hjorth SA; Schwartz TW; Portoghese PS
J Med Chem; 2000 Apr; 43(8):1573-6. PubMed ID: 10780914
[TBL] [Abstract][Full Text] [Related]
28. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
[TBL] [Abstract][Full Text] [Related]
29. Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.
Jacobs BA; Pando MM; Jennings EM; Jamshidi RJ; Zamora JC; Chavera TS; Clarke WP; Berg KA
Neuropharmacology; 2019 Jun; 151():208-218. PubMed ID: 30776373
[TBL] [Abstract][Full Text] [Related]
30. Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
Potter DN; Damez-Werno D; Carlezon WA; Cohen BM; Chartoff EH
Biol Psychiatry; 2011 Oct; 70(8):744-753. PubMed ID: 21757186
[TBL] [Abstract][Full Text] [Related]
31. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats.
Mitchell JM; Liang MT; Fields HL
Psychopharmacology (Berl); 2005 Nov; 182(3):384-92. PubMed ID: 16001119
[TBL] [Abstract][Full Text] [Related]
32. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
Robinson JD; McDonald PH
Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
[TBL] [Abstract][Full Text] [Related]
33. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
Kam AY; Chan AS; Wong YH
J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
[TBL] [Abstract][Full Text] [Related]
34. Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells.
Kam AY; Chan AS; Wong YH
J Pharmacol Exp Ther; 2004 Jul; 310(1):301-10. PubMed ID: 14996948
[TBL] [Abstract][Full Text] [Related]
35. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.
Huang P; Yakovleva T; Aldrich JV; Tunis J; Parry C; Liu-Chen LY
Neurosci Lett; 2016 Feb; 615():15-20. PubMed ID: 26780565
[TBL] [Abstract][Full Text] [Related]
36. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
[TBL] [Abstract][Full Text] [Related]
37. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Bruchas MR; Chavkin C
Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
[TBL] [Abstract][Full Text] [Related]
38. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
[TBL] [Abstract][Full Text] [Related]
39. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
Xiong W; Yu LC
Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
[TBL] [Abstract][Full Text] [Related]
40. Kappa-opioid antagonism impairs forebrain-dependent associative learning: A trace eyeblink conditioning study.
Loh RM; Galvez R
Behav Neurosci; 2015 Dec; 129(6):692-700. PubMed ID: 26501171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
